Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preparation, activity and use of piperidine protein farnesyltransferase inhibitors from LG Chemical

Sep. 2, 1999

Scotia's Foscan achieves positive results in phase III clinical trial

Sep. 1, 1999

New anticancer compound from Diatide shown to arrest tumor growth

Sep. 1, 1999

Progen receives provisional approval to undertake clinical studies of PI-88 at second site

Sep. 1, 1999

DuPont team presents new cdk inhibitors at ACS meeting

Aug. 31, 1999

Celecoxib NDA receives priority review designation for FAP

Aug. 31, 1999

Searle pays milestone to Epimmune for anticancer candidate

Aug. 31, 1999

LB-42908 inhibits protein farnesyltransferase in vitro, in vivo

Aug. 30, 1999

Preclinical studies of abetafen show potential for treatment of prostate disease

Aug. 30, 1999

Cytotoxic macrolide compounds HA-1 and TH-2 obtained from marine sources

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026